Small nucleolar RNA host gene 21 (SNHG21)

Small nucleolar RNA host gene 21 (SNHG21) is a long non-coding RNA (lncRNA) and a member of the small nucleolar RNA host gene family, which encompasses a class of lncRNAs often involved in regulating gene expression, DNA methylation, and RNA processing[1][2][3][5]. Like other SNHGs, SNHG21 may act as a molecular scaffold, regulate chromatin and gene transcription, or sponge microRNAs—mechanisms implicated in cellular proliferation, apoptosis, and oncogenesis[1][5]. Studies systematically analyzing the SNHG family reveal their dysregulation is correlated with tumor progression, patient prognosis, and drug sensitivity in cancer[2]. SNHG21’s specific mechanisms and disease roles have not been as extensively characterized as some other SNHG family members, and there is no current evidence it is directly targeted by drugs or has been developed as a therapeutic target[3][2]. SNHG21 is most appropriately categorized as a long non-coding RNA associated with broader regulatory functions and possible oncology biomarker potential within the SNHG gene family.

Other names

SCARNA15HGFSD2-AS1RP11-752G15.6FSD2 antisense RNA 1small nucleolar RNA host gene 21 (non-protein coding)

Not therapeutically targeted; mechanisms for the family include miRNA sponging and modulation of gene expression. Specific actions of SNHG21 in these roles not yet elucidated.